Braveheart Bio, Inc. Common Stock (BRVE)

Date: O: H: L: C: Vol:

Finanzdaten der Braveheart Bio, Inc. Common Stock-Aktie (BRVE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30
Periodenlänge	3 Monate
Operating Expenses	15.88
Operating Income/Loss	-15.88
Nonoperating Income/Loss	0.89
	-14.99
Attributable To Parent	-14.99
Available To Common Stockholders, Basic	-18.60
Basic Average Shares	7.40
Diluted Average Shares	7.40
Basic Earnings Per Share	-2.51
Diluted Earnings Per Share	-2.51